{"id":873019,"date":"2025-08-07T19:35:37","date_gmt":"2025-08-07T23:35:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/"},"modified":"2025-08-07T19:35:37","modified_gmt":"2025-08-07T23:35:37","slug":"doximity-acquires-pathway-a-leader-in-ai-clinical-reference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/","title":{"rendered":"Doximity Acquires Pathway, a Leader in AI Clinical Reference"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Doximity Acquires Pathway, a Leader in AI Clinical Reference<\/b><\/p>\n<p class=\"bwalignc\"><i>$63M acquisition brings physician AI team and datasets to Doximity\u2019s AI suite<\/i><\/p>\n<p>SAN FRANCISCO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nDoximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference.<\/p>\n<p>\nPhysicians make up half of Pathway\u2019s team. Over the past seven years, they\u2019ve assembled one of the largest structured datasets in medicine\u2014purpose-built for AI\u2014spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway\u2019s model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (USMLE) benchmark.<\/p>\n<p>\n\u201cWe\u2019re thrilled to welcome the Pathway team to Doximity,\u201d said Jeff Tangney, co-founder and CEO of Doximity. \u201cThey\u2019ve painstakingly built one of the best datasets in medicine, and it\u2019s going to take our clinical reference capabilities to an entirely new level.\u201d<\/p>\n<p>\n\u201cThere\u2019s a growing need for clinical tools that combine trusted evidence with the speed and adaptability of AI,\u201d said Jon Hershon, CEO of Pathway. \u201cHundreds of thousands of users have registered for Pathway, and thousands pay $300 per year for our premium product. With Doximity, one of the most trusted platforms in healthcare, we\u2019re now bringing that experience to millions for free, built directly into the tools they already use at the point of care.\u201d<\/p>\n<p>\nThe transaction closed on July 29, 2025 for cash consideration of $26 million and up to $37 million in additional equity grants.<\/p>\n<p><b>About Doximity<\/b><\/p>\n<p>\nFounded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company&#8217;s network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity&#8217;s mission is to help doctors be more productive so they can provide better care for their patients.<\/p>\n<p><b>About Pathway<\/b><\/p>\n<p>\nPathway helps clinicians deliver better, faster, more informed care by providing instant and evidence-based answers to medical questions. The AI-powered platform has hundreds of thousands of registered users, with a strong presence in the U.S. and internationally. The company is headquartered in Montreal, Canada.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250807262957\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250807262957\/en\/<\/a><\/span><\/p>\n<p><b>For investors:<br \/>\n<\/b><br \/>Perry Gold<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@doximity.com\">ir@doximity.com<\/a><\/p>\n<p><b>For media:<br \/>\n<\/b><br \/>Amanda Cox<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:pr@doximity.com\">pr@doximity.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Canada California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Software Practice Management Internet Health Artificial Intelligence Data Management Health Technology Technology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250807262957\/en\/2546220\/3\/dox-logotype-black-rgb_copy.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Doximity Acquires Pathway, a Leader in AI Clinical Reference $63M acquisition brings physician AI team and datasets to Doximity\u2019s AI suite SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway\u2019s team. Over the past seven years, they\u2019ve assembled one of the largest structured datasets in medicine\u2014purpose-built for AI\u2014spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway\u2019s model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (USMLE) benchmark. \u201cWe\u2019re thrilled to welcome the Pathway team to Doximity,\u201d &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Doximity Acquires Pathway, a Leader in AI Clinical Reference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-873019","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Doximity Acquires Pathway, a Leader in AI Clinical Reference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Doximity Acquires Pathway, a Leader in AI Clinical Reference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Doximity Acquires Pathway, a Leader in AI Clinical Reference $63M acquisition brings physician AI team and datasets to Doximity\u2019s AI suite SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway\u2019s team. Over the past seven years, they\u2019ve assembled one of the largest structured datasets in medicine\u2014purpose-built for AI\u2014spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway\u2019s model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (USMLE) benchmark. \u201cWe\u2019re thrilled to welcome the Pathway team to Doximity,\u201d &hellip; Continue reading &quot;Doximity Acquires Pathway, a Leader in AI Clinical Reference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-07T23:35:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Doximity Acquires Pathway, a Leader in AI Clinical Reference\",\"datePublished\":\"2025-08-07T23:35:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/\"},\"wordCount\":459,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/\",\"name\":\"Doximity Acquires Pathway, a Leader in AI Clinical Reference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-08-07T23:35:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Doximity Acquires Pathway, a Leader in AI Clinical Reference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Doximity Acquires Pathway, a Leader in AI Clinical Reference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/","og_locale":"en_US","og_type":"article","og_title":"Doximity Acquires Pathway, a Leader in AI Clinical Reference - Market Newsdesk","og_description":"Doximity Acquires Pathway, a Leader in AI Clinical Reference $63M acquisition brings physician AI team and datasets to Doximity\u2019s AI suite SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway\u2019s team. Over the past seven years, they\u2019ve assembled one of the largest structured datasets in medicine\u2014purpose-built for AI\u2014spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway\u2019s model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (USMLE) benchmark. \u201cWe\u2019re thrilled to welcome the Pathway team to Doximity,\u201d &hellip; Continue reading \"Doximity Acquires Pathway, a Leader in AI Clinical Reference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-07T23:35:37+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Doximity Acquires Pathway, a Leader in AI Clinical Reference","datePublished":"2025-08-07T23:35:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/"},"wordCount":459,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/","name":"Doximity Acquires Pathway, a Leader in AI Clinical Reference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-08-07T23:35:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250807262957r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/doximity-acquires-pathway-a-leader-in-ai-clinical-reference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Doximity Acquires Pathway, a Leader in AI Clinical Reference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/873019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=873019"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/873019\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=873019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=873019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=873019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}